(HealthDay): Pandemic-related disruptions in routine childhood vaccine coverage occurred worldwide in 2020, with the highest disruptions in April 2020, according to a study published online on July 14 a The Lancet.
Kate Causey, MPH, of the Seattle Institute of Health Metrics and Assessment, and her colleagues loved the interruptions in vaccine coverage associated with the global pandemic in 2020 and by the Global Burden of Disease (GBD) superregion. The numbers of children those who routinely stopped smoking the dose of the diphtheria-tetanus-pertussis vaccine (DTP3) and the measles vaccine (MCV1) first dose in 2020 were estimated.
The researchers found that by 2020, the estimated vaccine coverage was 76.7% for DTP3 and 78.9% for MCV1 globally, representing relative reductions of 7.7 and 7.9. %, respectively, compared to the expected doses delivered in the absence of the COVID-19 pandemic. An estimated 30.0 and 27.2 million children missed doses of DTP3 and MCV1, respectively, from January to December 2020. These estimates represent an additional 8.5 and 8.9 million children not routinely vaccinated with DTP3. and MCV1, respectively, attributable to the COVID-19 pandemic with projected gaps in coverage for eligible children in 2020. Monthly reductions were highest in April 2020 globally and each GBD supregion reduced the vaccine. coverage in March and April. During the second half of 2020, estimates suggested that monthly doses be given at previous or higher levels in some superregions.
“To move forward, the world should build on the lessons learned about adaptive and resilient routine vaccination programs during COVID-19 and strive to provide more equitable and sustainable sustainability. vaccine services for all, ”the authors write.
Copyright © 2021 HealthDay. All rights reserved.
Citation: The model calculates the routine doses of childhood vaccine lost during 2020 (2021, July 15) recovered on July 15, 2021 at https://medicalxpress.com/news/2021-07-routine-child-vaccine-doses .html
This document is subject to copyright. Apart from any fair treatment for private study or research purposes, no part may be reproduced without written permission. Content is provided for informational purposes only.